IBD Symposium
Fourth Annual Medical, Interventional & Surgical IBD Symposium
August 01, 2025
·
Vivian and Seymour Milstein Family Heart Center, 173 Fort Washington Ave, NYC
Program Overview
The Fourth Annual Medical, Interventional, Surgical IBD Symposium will bring together leading experts in gastroenterology, surgery, and interventional medicine to explore the latest advancements in the management and treatment of inflammatory bowel disease (IBD). This one-day, CME-accredited event will focus on medical therapies, diagnostic challenges, IBD mimics, complications, and surgical interventions. The program will feature lectures from renowned specialists, followed by a case discussion session to provide practical insights into complex clinical scenarios. The symposium is structured to provide in-depth knowledge and updates on the current state of IBD therapies, including biologics, small molecular agents, and endoscopic treatments. Experts will also present strategies for managing IBD complications, such as cancer risks and postoperative monitoring. The interactive case discussions will offer participants an opportunity to engage with the panel of experts to review real-world clinical cases.
Learning Objectives:
- Understand and apply the latest advancements in medical therapies for IBD, including anti-IL23 therapy, anti-TNF therapy, and small-molecule agents, to optimize patient outcomes.
- Evaluate and manage the diagnostic challenges of IBD, including differentiating IBD from IBD mimics and identifying complications such as adenocarcinoma and squamous cell carcinoma in IBD patients.
- Assess and develop individualized surgical treatment plans for IBD patients, including postoperative monitoring, endoscopic therapy, and the appropriate use of surgical interventions in Crohn’s disease and ulcerative colitis.
Target Audience
This program has been designed for regional, national, and worldwide audiences, including gastroenterologists, inflammatory bowel disease specialists, GI endoscopists, colorectal surgeons, general surgeons, GI pathologists, GI radiologists, NP/PA/RN in gastroenterology, IBD, and colorectal surgery, stoma nurses, medical students, medical/surgical residents, and GI/colorectal fellows.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians Assistants
PAs may claim a maximum of 6.50 AMA PRA Category 1 Credits™ for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Academy of Nurse Practitioners Certification Board (AANPCB) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum 6.50.
Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Refund Policy
Registration is limited and will be handled on a first-come, first-served basis. Telephone registrations/cancellations/refunds cannot be accepted.
Method of Participation
You will receive a confirmation email before the event with instructions for joining via Zoom and attending the Summit In-person instructions.
Tickets
Attending In-Person
MD, DO, PhD
175.00 USD
RN, NP, PA
150.00 USD
Fellows, Residents & Students, VIP
0.00 USD
Attending Virtually
MD, DO, PhD
150.00 USD
RN, NP, PA
100.00 USD
Fellows, Residents & Students, VIP
0.00 USD
Agenda
Friday, August 1
8:00 AM
8:00 AM
Event Start
8:00 AM - 8:50 AM
8:00 AM - 8:50 AM
Registration | Breakfast | Exhibit Hall
8:50 AM - 9:00 AM
8:50 AM - 9:00 AM
Welcome Remarks
Bo Shen, MD, NYP/Columbia University Irving Medical Center, NY
Ravi Kiran, MD, NYP/Columbia University Irving Medical Center, NY
Udayakumar Navaneethan, MD, Orlando Health, FL
9:00 AM
9:00 AM
SESSION I: MEDICAL THERAPY
Moderator: Bo Shen, MD, NYP/Columbia University Irving Medical Center, NY
9:00 AM - 9:20 AM
9:00 AM - 9:20 AM
Anti-IL23 therapy in IBD 2025
Gary Lichtenstein, MD, University of Pennsylvania, Philadelphia, PA
9:20 AM - 9:40 AM
9:20 AM - 9:40 AM
Update of anti-TNF therapy in IBD
Asher Kornbluth, MD, Mt Sinai Medical Center, New York, NY
9:40 AM - 10:00 AM
9:40 AM - 10:00 AM
Small molecular agents in IBD
Dana Lukin, MD, Cornell University, New York, NY
10:00 AM - 10:20 AM
10:00 AM - 10:20 AM
Monitoring safety issues in patients on biologics or small-molecule agents in IBD
Alexandra Gutierrez, MD, NYP/Columbia University Irving Medical Center, NY
10:20 AM - 10:30 AM
10:20 AM - 10:30 AM
Q & A
10:30 AM - 10:50 AM
10:30 AM - 10:50 AM
Break and Exhibits.
10:50 AM
10:50 AM
SESSION II: DIAGNOSIS AND MANAGEMENT CHALLENGES-IBD, IBD MIMICS, AND IBD COMPLICATIONS
Moderators: Udayakumar Navaneethan MD, Orlando Health, FL, and Bo Shen, MD, NYP/Columbia University Irving Medical Center, NY
10:50 AM - 11:10 AM
10:50 AM - 11:10 AM
Current celiac disease and other autoimmune disorders in IBD
Suneeta Krishnareddy, MD, Columbia University Irving Medical Center, NY
11:10 AM - 11:30 AM
11:10 AM - 11:30 AM
Risk of adenocarcinoma and squamous cell cancer in IBD
Ellen Scherl, MD, Weill Cornell University Medicine/NYP
11:30 AM - 11:50 AM
11:30 AM - 11:50 AM
Incorporation of intestinal ultrasound in the Management of IBD
Joseph A. Picoraro, MD, Columbia University Irving Medical Center/Morgan Stanley Children’s Hospital, NY
11:50 AM - 12:10 PM
11:50 AM - 12:10 PM
Update of endoscopic therapy for IBD complication
Bo Shen, MD, NYP/Columbia University Irving Medical Center, NY
12:10 PM - 12:20 PM
12:10 PM - 12:20 PM
Q & A
12:20 PM - 1:30 PM
12:20 PM - 1:30 PM
Lunch and Satellite Symposium
1:30 PM
1:30 PM
SESSION III. SURGERY, AND CASE DISCUSSION
Moderator: Ravi Kiran, MD, NYP/Columbia University Irving Medical Center, NY
1:30 PM - 1:50 PM
1:30 PM - 1:50 PM
Postoperative endoscopic monitoring and management of recurrent Crohn’s disease
Udayakumar Navaneethan, MD, Orlando Health, FL
1:50 PM - 2:10 PM
1:50 PM - 2:10 PM
Overview of surgical therapy in UC
Ravi Kiran, MD
NYP/Columbia University Irving Medical Center, NY
2:10 PM - 2:30 PM
2:10 PM - 2:30 PM
Pros and cons of end-to-side, side-to-side, and Kono-S anastomosis in CD
Marco Bertucci Zoccali, MD
NYP/Columbia University Irving Medical Center, NY
2:30 PM - 2:40 PM
2:30 PM - 2:40 PM
Q & A
2:40 PM - 4:25 PM
2:40 PM - 4:25 PM
Moderators: Udayakumar Navaneethan, MD and Bo Shen, MD
4:25 PM - 4:30 PM
4:25 PM - 4:30 PM
Adjourn
Bo Shen, MD, NYP/Columbia University Irving Medical Center, NY
Ravi Kiran, MD, NYP/Columbia University Irving Medical Center, NY Udayakumar Navaneethan, MD, Orlando Health, FL
4:30 PM
4:30 PM
Event End